Back

Impact of PCI versus optimal medical therapy on quality of life in patients with chronic total occlusions: NOBLE-CTO randomized controlled trial

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Navigating complexity: advances in chronic total occlusion interventions, physiology, and access management Chronic Total Occlusion (CTO) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marc Meller Brochner

Aalborg University Hospital, Aalborg (Denmark)

4 More presentations in this session

Presentation thumbnail
Impact of “Full Moon” calcification assessed by preprocedural cardiac computed tomography on guidewire crossing in percutaneous coronary intervention for chronic total occlusion: FULL MOON registry
Doctor Y. Nakano (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Reverse Barbeau test accuracy in the diagnosis of radial artery occlusion after transradial coronary catheterization
Doctor M. Didagelos (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Medium‑term mortality and safety of complex antegrade CTO-PCI in stable angina: a real world registry- observational comparison with optimised medical therapy
Doctor K. Kyaw (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Is there a difference between administering heparin before or after radial angiography?
Doctor F. Durak (Istanbul, TR)
Abstract Slides

Access the full session

Session thumbnail
Navigating complexity: advances in chronic total occlusion interventions, physiology, and access management

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Patient selection for chronic total occlusion recanalization in a dedicated outpatient clinic
29 August 2025
thumbnail
Congress Presentation
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
31 August 2025
thumbnail
Congress Presentation
Implication of myocardial perfusion abnormalities on clinical outcomes in patients undergoing percutaneous coronary intervention for chronic total occlusions
31 August 2025
thumbnail
Congress Presentation
Impact of biodegradable-polymer versus durable-polymer drug-eluting stents on clinical outcomes in patients with chronic total occlusion underwent successful percutaneous coronary intervention
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources